510(k) device
NeuroStar Advanced Therapy System (All previously cleared models)
Neuronetics, Inc. · Transcranial Magnetic Stimulator (OBP, Class II) · First FDA decision Nov 20, 2020, newest Mar 22, 2024DepressionOCD, PTSD and other psychiatric conditions
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
510(k) pathway
Device trials
3
Naming "NeuroStar Advanced Therapy"
MAUDE reports
115
Brand "NeuroStar Advanced Therapy", since 2015
PubMed studies
0
Mentioning "NeuroStar Advanced Therapy"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing NeuroStar Advanced Therapy System (All previously cleared models)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
K231926 · Decided Mar 22, 2024 · 266 days after receipt
Device type: Transcranial Magnetic Stimulator (OBP) · Neurology & Neurosurgery
K233621 · Decided Dec 13, 2023 · 30 days after receipt
Device type: Transcranial Magnetic Stimulator (OBP) · Neurology & Neurosurgery
K230029 · Decided Apr 4, 2023 · 90 days after receipt
Device type: Transcranial Magnetic Stimulator (OBP) · Neurology & Neurosurgery
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcranial Magnetic StimulationLocal determinationIn effectL33398Wellpoint FederalUpdated Jul 16, 2026
- Transcranial Magnetic StimulationProposed local determinationProposedDL33398National Government Services, Inc.Updated Mar 27, 2026
- Transcranial Magnetic Stimulation (TMS)Local determinationIn effectL34641WPS Insurance CorporationUpdated Mar 20, 2026
- Transcranial Magnetic Stimulation (TMS)Local determinationIn effectL37086Noridian Healthcare Solutions, LLCUpdated Aug 6, 2025
- Repetitive Transcranial Magnetic Stimulation (rTMS) in AdultsLocal determinationIn effectL34869Palmetto GBAUpdated Jan 7, 2025
- Transcranial Magnetic Stimulation (TMS)Local determinationIn effectL36469CGS Administrators, LLCUpdated May 30, 2024
- Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive DisorderLocal determinationIn effectL34522First Coast Service Options, Inc.Updated Oct 21, 2022
- Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive DisorderLocal determinationIn effectL34998Novitas Solutions, Inc.Updated Oct 21, 2022
Clinical trials
Device studies on ClinicalTrials.gov that name "NeuroStar Advanced Therapy", any status and sponsor, newest update first.
NeuroneticsAcademic, hospital or other
NCT06917339 · 156,000 participants (planned) · Start Feb 25, 2025 · Primary completion Dec 2035
Device: NeuroStar Advanced TMS Therapy System · For: Depression; Obsessive-Compulsive Disorder; Anxiety Depression
Sites: Malvern, Pennsylvania
NeuroneticsAcademic, hospital or other
NCT06699940 · 7,690 participants · Start May 1, 2023 · Primary completion May 1, 2023
Device: Transcranial Magnetic Stimulation · For: MDD
Sites: Malvern, Pennsylvania
NeuroneticsAcademic, hospital or other
NCT04217837 · 0 participants · Start Mar 2020 · Primary completion Feb 2022
Device: Transcranial Magnetic Stimulator · For: Major Depressive Disorder
Sites: London, United Kingdom
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "NeuroStar Advanced Therapy", and for the whole product code for context.
This brand
115 reports: 0 malfunction, 115 injury, 0 death
Whole product code OBP
337 reports: 9 malfunction, 323 injury, 2 death
Newest reports for this brand
3004824012-2026-00024 · Received Oct 2, 2026 · Event dated Aug 26, 2026
Device type: Transcranial Magnetic Stimulator (OBP)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Convulsion/Seizure
3004824012-2026-00022 · Received Sep 28, 2026 · Event dated Aug 28, 2026
Device type: Transcranial Magnetic Stimulation System For Obsessive-Compulsive Disorder (QCI)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Convulsion/Seizure
3004824012-2026-00021 · Received Sep 18, 2026 · Event dated Aug 21, 2026
Device type: Transcranial Magnetic Stimulator (OBP)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Convulsion/Seizure
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0142-2027 · Started Aug 24, 2026 · Posted by FDA Oct 9, 2026
Reason given: Cables are not in conformance with the product specifications required in the production of the HP Coil Assembly.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Transcranial Magnetic Stimulator (OBP)
Published research
The most relevant PubMed records for "NeuroStar Advanced Therapy"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OBP.
- NeuroStar TMS Therapy SystemNeuronetics, Inc. · 510(k) 2022
- BrainsWay Deep TMS SystemBrainsway , Ltd. · 510(k) 2025
- Apollo TMS Therapy SystemMag & More GmbH · 510(k) 2026
- MagVita TMS Therapy w/MagPro R20Tonica Elektronik A/S · 510(k) 2017
- Magstim Horizon 3.0 TMS Therapy SystemMagstim Company, Ltd. · 510(k) 2023
- HORIZON TMS Therapy System with NavigationMagstim Company, Ltd. · 510(k) 2019
- Nexstim Navigated Brain Stimulation (NBS) 6 System (NBS6)Nexstim Oyj · 510(k) 2026
- MagVenture TMS Therapy SystemTonica Elektronik A/S · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.